Entegrion
Business Services · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4819 Emperor Blvd Ste 400, Durham, North...Phone Number
(919) 536-1500Website
www.entegrion.comRevenue
$5.7 MillionIndustry
About Entegrion
Entegrion Org Chart
Is Entegrion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Entegrion has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Entegrion launches new products
Congratulate Masked Content for being promoted to Masked Content at Entegrion
Check if Entegrion has recently received funding, and reach out quickly before it becomes old news!
Check out if Entegrion is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Entegrion, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Entegrion had a recent Job posting/layoffs
Earning: See what the market has to say on Entegrion recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Entegrion as Masked Content
Find 3 more new buyers
Compare Similar Companies to Entegrion
Compare insights from companies similar to Entegrion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Entegrion is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Entegrion is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Entegrion.
Entegrion financials insights
Gather financial insights about Entegrion, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$1.5M
Debt
$5.6M
Other Financing Round
$13.8M
Entegrion Tech Stack
A closer look at the technologies used by Entegrion
Most Recent Scoops
Entegrion News & Media
Multimodal Protocol for Anticoagulation Monitoring in ECMO Patients: Safety Analysis of Anti-Xa and VCM Monitoring
Point of Care Testing May Have the Potential to Estimate Anti-Xa Values Without the Need for a Laboratory Test DURHAM, NC, UNITED STATES, November 11, 2024 /EINPresswire.com/ -- Entegrion, Inc., a leading developer of innovative solutions for clinical …VCM Heparinase Test to Monitor Anticoagulation Level to Predict Platelet Transfusion in ECMO patients
VCM Maximum Clot Formation (MCF) Outperforms Other Viscoelastic Tests DURHAM, NC, UNITED STATES, November 5, 2024 /EINPresswire.com/ -- Entegrion, Inc., a leading developer of innovative solutions for clinical diagnosis and management of hemostasis, …Entegrion, Inc. Announces the Expansion of Commercial Operations in Europe
With the accelerated acceptance for the need of point of care viscoelastic coagulation testing worldwide, Entegrion has launched Entegrion Italia S.R.L.. DURHAM, NORTH CAROLINA, USA, November 11, 2022 /EINPresswire.com/ -- Entegrion, Inc., a leading …Entegrion, Inc. and Velico Medical Enter Into Intellectual Property Transfer Agreement For Spray Dried Plasma
Resusix, pooled, pathogen reduced, dehydrated plasma product line will be added to Velico’s expanding plasma products portfolio. DURHAM, NORTH CAROLINA, USA, August 1, 2022 /EINPresswire.com/ -- Entegrion, Inc., a leading developer of innovative …
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Entegrion
Entegrion is a life sciences company that is focused on improving the diagnosis and treatment of hemostasis and related transfusion needs. Based in North Carolina's Research Triangle Park, Entegrion offers patented technologies designed to improve diagnostics, and overcome limitations in storage, safety, and availability of blood-derived products w... Read More